MedPath

Restylane Perlane to Shape the Nasal Dorsum and/or Nasal Root

Not Applicable
Completed
Conditions
Nasal Augmentation
Interventions
Device: Restylane Perlane
Registration Number
NCT02216851
Lead Sponsor
Galderma R&D
Brief Summary

The purpose of this study is to determine the safety and efficacy of using Restylane Perlane to shape the nasal dorsum and/or nasal root in comparison with a no-treatment control group

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
132
Inclusion Criteria
  • Chinese origin
  • Subject with desire to shape the nasal dorsum and/or nasal root
  • Subjects who, in the opinion of the investigator, can achieve a clinically meaningful aesthetic correction of their nose with ≤ 1 ml Restylane Perlane
Exclusion Criteria
  • Subjects with previous nasal surgery, including grafts or implants to the nose area
  • Subjects requiring filler treatment around the tip of the nose or between the eyebrows (glabella region) to achieve a good aesthetic outcome
  • Subjects with a history of chronic sinusitis or rhinitis
  • Subjects who have previously received aesthetic treatment in the forehead, glabellar and/or nose area with a dermal filler

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Restylane PerlaneRestylane PerlaneSingle injection of Restylane Perlane in nasal dorsum and/or nasal root
Primary Outcome Measures
NameTimeMethod
Mean Difference of Change in Volume (mL) at 6 Months After Baseline Versus Pre-treatment in the Nasal Dorsum/Nasal Root Between Restylane Perlane Treatment Group and No-treatment Control6 months

The primary objective of the study was to evaluate the efficacy of Restylane Perlane in shaping the nasal dorsum and/or nasal root as compared to no-treatment control, by assessment of the primary endpoint:The change in volume will be measured using 3 D photography technique.

The change in volume was calculated as the value at 6 months of treatment group compared with non-treatment group

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath